You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RRMM

Showing 126 - 150 of 174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Learn About Medicine in People With Relapsed Refractory Multiple

Completed
  • Multiple Myeloma
  • New York, New York
    Pfizer
Nov 14, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Fountain Valley, California
  • +107 more
Dec 7, 2022

Multiple Myeloma, Relapsed and Refractory Multiple Myeloma, Genetic Condition Trial (Ixazomib/Pomalidomide/Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • (no location specified)
Sep 22, 2018

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 1, 2023

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Bakersfield, California
  • +58 more
Oct 15, 2020

People With Multiple Myeloma in Portugal

Recruiting
  • Relapse and/or Refractory Multiple Myeloma
    • Braga, Portugal
    • +7 more
    Jun 9, 2022

    Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in San Francisco (Pembrolizumab)

    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Pembrolizumab
    • San Francisco, California
      University of California, San Francisco
    Mar 23, 2022

    Hematologic Malignancies Trial in Japan (Teclistamab)

    Recruiting
    • Hematologic Malignancies
    • Chiba, Japan
    • +14 more
    Aug 11, 2022

    Multiple Myeloma Trial in Belgium, France, United States (EOS884448, Iberdomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Hackensack, New Jersey
    • +3 more
    Jun 15, 2022

    Myeloma, Multiple, Myeloma-Multiple Trial run by the NCI (Avelumab, External beam radiotherapy)

    Terminated
    Has Results
    • Myeloma, Multiple
    • Myeloma-Multiple
    • Avelumab
    • External beam radiotherapy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 19, 2021

    Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Pomalidomide)

    Active, not recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Birmingham, Alabama
    • +45 more
    Dec 6, 2022

    Relapsed and/or Refractory Multiple Myeloma Trial in United States (Melphalan Flufenamide, Dexamethasone)

    Approved for marketing
    • Relapsed and/or Refractory Multiple Myeloma
    • Springdale, Arkansas
    • +10 more
    Mar 16, 2021

    Multiple Myeloma Trial in Charlotte (Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin)

    Recruiting
    • Multiple Myeloma
    • Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin
    • Charlotte, North Carolina
      Levine Cancer Institute
    Nov 17, 2021

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 30, 2021

    Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in Milwaukee (Belantamab mafodotin)

    Recruiting
    • Refractory Multiple Myeloma
    • Relapse Multiple Myeloma
    • Belantamab mafodotin
    • Milwaukee, Wisconsin
      Froedtert & the Medical College of Wisconsin
    Aug 3, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, t(11;14) Negative Trial (Dexamethasone, Ixazomib, Ixazomib

    Withdrawn
    • Recurrent Plasma Cell Myeloma
    • +2 more
    • (no location specified)
    Mar 25, 2019

    Relapsed or Refractory Multiple Myeloma Trial in United States (Dexamethasone, Carfilzomib)

    Terminated
    Has Results
    • Relapsed or Refractory Multiple Myeloma
    • Palm Springs, California
    • +30 more
    Dec 14, 2020

    Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • New York, New York
      Icahn School of Medicine
    Jan 20, 2023

    Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

    Completed
    • Myeloma Multiple
    • +3 more
    • Afula, Israel
    • +13 more
    Jan 26, 2022

    Relapsed or Refractory Multiple Myeloma Trial in United States (CAR2 Anti-CD38 A2 CAR-T Cells)

    Completed
    • Relapsed or Refractory Multiple Myeloma
    • CAR2 Anti-CD38 A2 CAR-T Cells
    • Jacksonville, Florida
    • +3 more
    Mar 14, 2022

    Investigate eNAMPT in Multiple Myeloma Biology and Establish Its

    Recruiting
    • Multiple Myeloma
      • Torino, TO, Italy
        Aou Citta' Della Salute E Della Scienza Di Torino
      Aug 17, 2021

      Newly Diagnosed Multiple Myeloma Trial in Spain (Bortezomib, Isatuximab, Iberdomide)

      Not yet recruiting
      • Newly Diagnosed Multiple Myeloma
      • Alcalá de Henares, Madrid, Spain
      • +67 more
      Sep 23, 2022